[go: up one dir, main page]

MX2009011494A - Marcadores de enfermedades. - Google Patents

Marcadores de enfermedades.

Info

Publication number
MX2009011494A
MX2009011494A MX2009011494A MX2009011494A MX2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A MX 2009011494 A MX2009011494 A MX 2009011494A
Authority
MX
Mexico
Prior art keywords
disease markers
autoimmune disease
subject
biomarkers
leukocytes
Prior art date
Application number
MX2009011494A
Other languages
English (en)
Inventor
David Wraith
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Publication of MX2009011494A publication Critical patent/MX2009011494A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a biomarcadores para enfermedades autoinmunitarias, y en particular, a un método para la determinación del estado de una enfermedad autoinmunitaria en un sujeto de ensayo, que comprende la medición de la producción de una citoquina Th2 por leucocitos del sujeto; al igual que a usos y equipos asociados.
MX2009011494A 2007-04-24 2008-04-23 Marcadores de enfermedades. MX2009011494A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0707933.8A GB0707933D0 (en) 2007-04-24 2007-04-24 Disease markers
PCT/GB2008/001415 WO2008129296A2 (en) 2007-04-24 2008-04-23 Disease markers

Publications (1)

Publication Number Publication Date
MX2009011494A true MX2009011494A (es) 2009-11-09

Family

ID=38135366

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011494A MX2009011494A (es) 2007-04-24 2008-04-23 Marcadores de enfermedades.

Country Status (13)

Country Link
US (1) US20100129853A1 (es)
EP (1) EP2156190A2 (es)
JP (1) JP2010525355A (es)
CN (1) CN102317787A (es)
AU (1) AU2008240367A1 (es)
BR (1) BRPI0810559A2 (es)
CA (1) CA2685113A1 (es)
GB (1) GB0707933D0 (es)
MX (1) MX2009011494A (es)
NO (1) NO20093384L (es)
PL (1) PL391035A1 (es)
RU (1) RU2009142935A (es)
WO (1) WO2008129296A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
CA2878025C (en) 2008-01-18 2018-12-11 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
GB0903391D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Biomarkers
JP2013520208A (ja) * 2010-02-24 2013-06-06 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ 自己免疫疾患の診断、予後判定、及び処置法
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
GB201400562D0 (en) 2014-01-14 2014-03-05 Orla Protein Technologies Ltd Protein coated polymeric substrate
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695713B2 (en) * 2002-08-08 2010-04-13 Baylor College Of Medicine Isolation and identification of T cells
DE602004030586D1 (de) * 2003-09-15 2011-01-27 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Also Published As

Publication number Publication date
EP2156190A2 (en) 2010-02-24
JP2010525355A (ja) 2010-07-22
CA2685113A1 (en) 2008-10-30
PL391035A1 (pl) 2010-10-25
BRPI0810559A2 (pt) 2015-02-10
NO20093384L (no) 2010-01-18
CN102317787A (zh) 2012-01-11
GB0707933D0 (en) 2007-05-30
WO2008129296A3 (en) 2008-12-11
RU2009142935A (ru) 2011-05-27
US20100129853A1 (en) 2010-05-27
AU2008240367A1 (en) 2008-10-30
WO2008129296A2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
MX2009011494A (es) Marcadores de enfermedades.
NZ606725A (en) Methods for predicting anti-cancer response
MX340453B (es) Biomarcadores para cancer de pulmon.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
IN2014CN01970A (es)
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
WO2011128357A3 (en) Biomarkers for hypertensive disorders of pregnancy
WO2011011426A8 (en) Methods for assessing disease risk
WO2010068686A3 (en) Methods of diagnosing and predicting renal disease
MX2009011007A (es) Biomarcadores para esclerosis multiple.
WO2013052505A3 (en) Methods and devices for assessing risk to a putative offspring of developing a condition
CY1111811T1 (el) Μεθοδοι ms για την αξιολογηση γλυκανων
WO2010005982A3 (en) Multiplexed biomarkers of insulin resistance
ATE438856T1 (de) Biomarker für eierstockkrebs: mit ctap3 verwandte proteine
WO2011106709A3 (en) Epithelial biomarkers for cancer prognosis
WO2010087594A3 (ko) 시디９３ 또는 이의 가용성 단편의 용도
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2007089734A3 (en) Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
GB201014837D0 (en) Biomarker signatures and uses thereof
WO2013044187A3 (en) Detecting ovarian cancer
HK1225298A1 (zh) Cd6结合配对体的使用和以其为基础的方法
WO2006034032A3 (en) Biomarkers for breast cancer
WO2013009146A3 (ko) 당뇨망막병증 진단용 마커 및 이의 용도
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
FA Abandonment or withdrawal